A Volume-Adjustable Artificial Womb for Extremely Preterm Infants

Jan Heyer1, Franziska Schubert1, Alexander L Seitz1

  • 1Department of Cardiovascular Engineering, Institute of Applied Medical Engineering, Helmholtz Institute, RWTH Aachen University and University Hospital, Aachen, Germany.

Insights

Developing an artificial womb, this bridge-to-life technology supports extremely preterm infants by providing a physiological liquid environment for organ maturation. The system demonstrates adaptability to fetal growth and maintains stable conditions for up to 7 days.

Area of Science:

  • Neonatal medicine
  • Biomedical engineering
  • Developmental biology

Background:

  • Over 13 million children are born preterm annually, with prematurity causing 0.9 million global deaths.
  • Extremely preterm infants (gestational age < 28 weeks) face organ failure and specific morbidities due to immaturity.
  • Existing treatments for extreme prematurity have limited success in preventing mortality and long-term complications.

Purpose of the Study:

  • To develop and evaluate an artificial womb and placenta technology as a bridge-to-life solution for extremely preterm neonates.
  • To create a system that supports physiological organ maturation in a liquid environment, mimicking in utero conditions.
  • To design an adaptable artificial womb capable of accommodating fetal growth over a defined period.

Main Methods:

  • An artificial womb system was designed with adjustable inner sac volume (3.6–7.0 L) using fluid removal between chambers.
  • A filtration and disinfection system was developed to manage metabolic waste and prevent phospholipid washout.
  • In vitro testing was conducted over 7 days to assess temperature stability (36.8°C ± 0.3°C) and pressure integrity.

Main Results:

  • The artificial womb maintained a stable temperature of 36.8°C ± 0.3°C without pressure loss for 7 days.
  • The system demonstrated effective filtration, disinfection, and prevention of phospholipid washout.
  • The volume variability of the artificial womb was sufficient to support physiological growth for 4 weeks.

Conclusions:

  • The artificial womb technology shows promise as a bridge-to-life solution for extremely preterm infants.
  • The system's ability to adapt to fetal growth and maintain physiological conditions is a significant advancement.
  • Further development of this technology could reduce prematurity-related mortality and morbidity.